Connect your AI

Pacira BioSciences, Inc. PCRX Taxes Paid

Taxes Paid at other companies

Avanos MedicalAVNS

$3.53M—

Collegium Pharmaceutical, Inc.COLL

$44K-98.2%

AtriCureATRC

$91K-21.6%

Other financials

Income statement

Revenue$177.4M+5.0%

Gross profit$141.0M+4.7%

Operating income$6.9M+247%

Net income$2.9M-39.4%

EPS (diluted)$0.07-30.0%

Balance sheet

Cash & equivalents$144.3M-49.1%

Total debt$411.2M+15.3%

Total equity$653.9M-18.1%

Total assets$1.2B-23.8%

Cash flow

Operating cash flow$25.7M-27.6%

CapEx$2.7M-68.1%

Free cash flow$23.0M-14.7%

Valuation

Market cap$942.78M-14.5%

Enterprise value$1.21B+2.6%

P/E183.5×—

P/S1.3×-0.3×

Profitability

Gross margin79.3%+1.7pp

Operating margin3.3%—

Net margin0.7%—

FCF margin18.1%-4.6pp

Returns & leverage

Return on equity0.7%—

Debt / equity0.6×+0.2×

Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pacira BioSciences, Inc.'s taxes paid?: Pacira BioSciences, Inc. (PCRX) reported taxes paid of $50K in Q1 2026.
How has Pacira BioSciences, Inc.'s taxes paid changed year-over-year?: Pacira BioSciences, Inc.'s taxes paid decreased by 82.5% year-over-year, from $286K to $50K.
What is the long-term trend for Pacira BioSciences, Inc.'s taxes paid?: Over 3 years (2021 to 2024), Pacira BioSciences, Inc.'s taxes paid has grown at a 50.7% compound annual growth rate (CAGR), from $3.22M to $11.02M.
What does taxes paid mean?: Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.